Reyataz
Product Images NDC 67296-1236

1 FDA label image from Redpharm Drug, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Reyataz (NDC 67296-1236). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Reyataz 300mg (Doc20170511110456 001)

Reyataz 300mg (Doc20170511110456 001)
Label for REYATAZ 300 MG capsules, showing prescription-only status with package containing 4 capsules. The label includes lot number, expiration date 05/17, storage instructions at controlled room temperature, and manufacturer as Bristol-Myers Squibb Co., labeled by RedPharm Drug, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.